Blue Earth Therapeutics Announces Clinical Research Collaboration With Ucl to Develop Innovative Alpha-Labelled Radioligand Therapy (Rlt) for Prostate Cancer
藍地球生物宣佈與UCL合作開發創新的α-標記的放射性配體治療(RLT)前列腺癌的臨床研究。
Blue Earth Therapeutics Announces Clinical Research Collaboration With Ucl to Develop Innovative Alpha-Labelled Radioligand Therapy (Rlt) for Prostate Cancer
藍地球生物宣佈與UCL合作開發創新的α-標記的放射性配體治療(RLT)前列腺癌的臨床研究。
譯文內容由第三人軟體翻譯。